MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma

Abstract Background Combined hepatocellular-cholangiocarcinoma (cHCC-CC) is a rare primary liver tumor, which has overlapping imaging features with mass forming intra-hepatic cholangiocarcinoma (ICC) and hepatocellular carcinoma (HCC). Previous studies reported imaging features more closely resemble...

Full description

Bibliographic Details
Main Authors: Jennifer Sammon, Sandra Fischer, Ravi Menezes, Hooman Hosseini-Nik, Sara Lewis, Bachir Taouli, Kartik Jhaveri
Format: Article
Language:English
Published: BMC 2018-02-01
Series:Cancer Imaging
Subjects:
Online Access:http://link.springer.com/article/10.1186/s40644-018-0142-z
id doaj-dba0f881afd740c5a56333d7a1d074b9
record_format Article
spelling doaj-dba0f881afd740c5a56333d7a1d074b92021-03-02T07:22:36ZengBMCCancer Imaging1470-73302018-02-011811910.1186/s40644-018-0142-zMRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinomaJennifer Sammon0Sandra Fischer1Ravi Menezes2Hooman Hosseini-Nik3Sara Lewis4Bachir Taouli5Kartik Jhaveri6Toronto Joint Department of Medical Imaging, University Health Network, Sinai Health System and Women’s College Hospitals, University of TorontoDepartment of Pathology, University Health Network, University of TorontoToronto Joint Department of Medical Imaging, University Health Network, Sinai Health System and Women’s College Hospitals, University of TorontoToronto Joint Department of Medical Imaging, University Health Network, Sinai Health System and Women’s College Hospitals, University of TorontoDepartment of Radiology, Mount Sinai New YorkDepartment of Radiology, Mount Sinai New YorkToronto Joint Department of Medical Imaging, University Health Network, Sinai Health System and Women’s College Hospitals, University of TorontoAbstract Background Combined hepatocellular-cholangiocarcinoma (cHCC-CC) is a rare primary liver tumor, which has overlapping imaging features with mass forming intra-hepatic cholangiocarcinoma (ICC) and hepatocellular carcinoma (HCC). Previous studies reported imaging features more closely resemble ICC and the aim of our study was to examine the differential MRI features of cHCC-CC and ICC with emphasis on enhancement pattern observations of gadolinium enhanced MRI. Methods Institutional review board approval with consent waiver was obtained for this retrospective bi-centric study. Thirty-three patients with pathologically proven cHCC-CC and thirty-eight patients with pathologically proven ICC, who had pre-operative MRI, were identified. MRI images were analyzed for tumor location and size, T1 and T2 signal characteristics, the presence/absence of: cirrhosis, intra-lesional fat, hemorrhage/hemosiderin, scar, capsular retraction, tumor thrombus, biliary dilatation, degree of arterial enhancement, enhancement pattern, pseudocapsule and washout. Associations between MRI features and tumor type were examined using the Fisher’s exact and chi-square tests. Results Strong arterial phase enhancement and the presence of: washout, washout and progression, intra-lesional fat and hemorrhage were all strongly associated with cHCC-CC (P < 0.001). While cHCC-CC had a varied enhancement pattern, the two most common enhancement patterns were peripheral persistent (n = 6) and heterogeneous hyperenhancement with washout (n = 6), compared to ICC where the most common enhancement patterns were peripheral hypoenhancement with progression (n = 18) followed by heterogeneous hypoenhancement with progression (n = 14) (P < 0.001). Conclusion The cHCC-CC enhancement pattern seems to more closely resemble HCC with the degree of arterial hyperenhancement and the presence of washout being valuable in differentiating cHCC-CC from ICC. However the presence of washout and progression, in the same lesion or a predominantly peripheral /rim hyperenhancing mass were also seen as important features that should alert the radiologist to the possibility of a cHCC-CC.http://link.springer.com/article/10.1186/s40644-018-0142-zCombined hepatocellular-cholangiocarcinomaIntrahepatic cholangiocarcinomaBiphenotypic tumorLiver MRIPrimary liver tumor
collection DOAJ
language English
format Article
sources DOAJ
author Jennifer Sammon
Sandra Fischer
Ravi Menezes
Hooman Hosseini-Nik
Sara Lewis
Bachir Taouli
Kartik Jhaveri
spellingShingle Jennifer Sammon
Sandra Fischer
Ravi Menezes
Hooman Hosseini-Nik
Sara Lewis
Bachir Taouli
Kartik Jhaveri
MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma
Cancer Imaging
Combined hepatocellular-cholangiocarcinoma
Intrahepatic cholangiocarcinoma
Biphenotypic tumor
Liver MRI
Primary liver tumor
author_facet Jennifer Sammon
Sandra Fischer
Ravi Menezes
Hooman Hosseini-Nik
Sara Lewis
Bachir Taouli
Kartik Jhaveri
author_sort Jennifer Sammon
title MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma
title_short MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma
title_full MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma
title_fullStr MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma
title_full_unstemmed MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma
title_sort mri features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma
publisher BMC
series Cancer Imaging
issn 1470-7330
publishDate 2018-02-01
description Abstract Background Combined hepatocellular-cholangiocarcinoma (cHCC-CC) is a rare primary liver tumor, which has overlapping imaging features with mass forming intra-hepatic cholangiocarcinoma (ICC) and hepatocellular carcinoma (HCC). Previous studies reported imaging features more closely resemble ICC and the aim of our study was to examine the differential MRI features of cHCC-CC and ICC with emphasis on enhancement pattern observations of gadolinium enhanced MRI. Methods Institutional review board approval with consent waiver was obtained for this retrospective bi-centric study. Thirty-three patients with pathologically proven cHCC-CC and thirty-eight patients with pathologically proven ICC, who had pre-operative MRI, were identified. MRI images were analyzed for tumor location and size, T1 and T2 signal characteristics, the presence/absence of: cirrhosis, intra-lesional fat, hemorrhage/hemosiderin, scar, capsular retraction, tumor thrombus, biliary dilatation, degree of arterial enhancement, enhancement pattern, pseudocapsule and washout. Associations between MRI features and tumor type were examined using the Fisher’s exact and chi-square tests. Results Strong arterial phase enhancement and the presence of: washout, washout and progression, intra-lesional fat and hemorrhage were all strongly associated with cHCC-CC (P < 0.001). While cHCC-CC had a varied enhancement pattern, the two most common enhancement patterns were peripheral persistent (n = 6) and heterogeneous hyperenhancement with washout (n = 6), compared to ICC where the most common enhancement patterns were peripheral hypoenhancement with progression (n = 18) followed by heterogeneous hypoenhancement with progression (n = 14) (P < 0.001). Conclusion The cHCC-CC enhancement pattern seems to more closely resemble HCC with the degree of arterial hyperenhancement and the presence of washout being valuable in differentiating cHCC-CC from ICC. However the presence of washout and progression, in the same lesion or a predominantly peripheral /rim hyperenhancing mass were also seen as important features that should alert the radiologist to the possibility of a cHCC-CC.
topic Combined hepatocellular-cholangiocarcinoma
Intrahepatic cholangiocarcinoma
Biphenotypic tumor
Liver MRI
Primary liver tumor
url http://link.springer.com/article/10.1186/s40644-018-0142-z
work_keys_str_mv AT jennifersammon mrifeaturesofcombinedhepatocellularcholangiocarcinomaversusmassformingintrahepaticcholangiocarcinoma
AT sandrafischer mrifeaturesofcombinedhepatocellularcholangiocarcinomaversusmassformingintrahepaticcholangiocarcinoma
AT ravimenezes mrifeaturesofcombinedhepatocellularcholangiocarcinomaversusmassformingintrahepaticcholangiocarcinoma
AT hoomanhosseininik mrifeaturesofcombinedhepatocellularcholangiocarcinomaversusmassformingintrahepaticcholangiocarcinoma
AT saralewis mrifeaturesofcombinedhepatocellularcholangiocarcinomaversusmassformingintrahepaticcholangiocarcinoma
AT bachirtaouli mrifeaturesofcombinedhepatocellularcholangiocarcinomaversusmassformingintrahepaticcholangiocarcinoma
AT kartikjhaveri mrifeaturesofcombinedhepatocellularcholangiocarcinomaversusmassformingintrahepaticcholangiocarcinoma
_version_ 1724241600559710208